Posted by Michael Wonder on 15 Jun 2023
Sandoz introduces Act4Biosimilars Action Plan to accelerate patient access to biosimilar medicines
15 June 2023 - Despite nearly 20 years of availability, biosimilars show worldwide adoption rate of only 14% in initiative-tracked countries, while reference medicines still represent 86% of biologic treatments.
Sandoz today announced the launch of a global roadmap to increase patient access to biologic medicines.
